2017;7:42477 Gilat T, Leikin-Frenkel A, Goldiner L, et al
Semaglutide is not recommended during pregnancy, and due to its long washout period, the MHRA advises discontinuing Ozempic at least two months before a planned pregnancy to ensure the medication is cleared from the system
-
To combat potential gastrointestinal adverse effects, physicians should prescribe a lower dose initially and titrate slowly or use the extended-release formulation to improve tolerance
The genes analyzed included insulin receptor (InsR), insulin receptor substrate-1 (IRS-1), tumor necrosis factor-alpha (TNF-), nuclear factor-kappa B-1 (NFB-1), interleukin-6 (IL-6), caspase-3, Bcl-2-associated protein X (Bax), and B-cell lymphoma 2 (Bcl-2), with -actin selected as the endogenous housekeeping gene (Table 6) 67
What Is the Long-Term Outlook